FIELD: medicine.
SUBSTANCE: method involves per os administering Hepatosan at a dose of 0.8 g/day. The total treatment course is 2 months long.
EFFECT: high activity of 7-α hydroxylase; no adverse side effects observed.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR STUDYING BILE ACIDS AND CHOLESTEROL METABOLISM | 2004 |
|
RU2260184C1 |
| PHARMACEUTICAL COMPOSITION BASED ON HEPATOPROTECTOR AND PREBIOTIC AND METHOD FOR PRODUCING AND APPLYING THE COMPOSITION | 2006 |
|
RU2318538C1 |
| METHOD FOR SELECTION OF REHABILITATION THERAPY FOR PATIENTS WITH CHRONICAL CHOLECYSTITIS IN REMISSION PHASE | 2007 |
|
RU2347571C2 |
| METHOD FOR EARLY DIAGNOSTICS OF CHOLELITHIASIS | 2004 |
|
RU2254809C1 |
| METHOD FOR TREATMENT OF DISEASES CAUSED AND ACCOMPANYING DISTURBANCE IN METABOLISM OF BILE ACIDS AND CHOLESTEROL | 2005 |
|
RU2294207C2 |
| METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 |
|
RU2813033C1 |
| METHOD OF TREATING PATIENTS SUFFERING FROM FIRST STAGE CHOLELITHIASIS | 2012 |
|
RU2519198C2 |
| AGENT BASED ON L-RHAMNOPYRANOSYL-6-O-METHYL-D-GALACTURONANE, HAVING HYPOLIPIDEMIC ACTIVITY | 2019 |
|
RU2699802C1 |
| MEDICINAL-PROPHYLAXIS AGENT OF CHOLESTEROL-REGULATING ACTION AND A METHOD OF DISEASE TREATMENT CAUSED CHOLESTEROL METABOLISM DAMAGE IN ORGANISM | 1993 |
|
RU2043111C1 |
| METHOD FOR BIOCHEMICAL EVALUATION OF METABOLIC DISORDERS IN BILE ACCOMPANYING LITHOGENESIS | 2015 |
|
RU2593340C1 |
